Tech Company Financing Transactions
Oxurion Funding Round
On 3/5/2024, Oxurion secured $328 thousand in funding from private investors.
Transaction Overview
Company Name
Announced On
3/5/2024
Transaction Type
Venture Equity
Amount
$328,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
Gaston Geenslaan 1
Leuven, B-3001
Belgium
Leuven, B-3001
Belgium
Phone
Undisclosed
Website
Email Address
Overview
Oxurion is a biopharmaceutical company developing next generation therapies, designed to improve and better preserve vision in patients with retinal disorders including Geographic Atrophy, the leading cause of vision loss in elderly people worldwide.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Charles de Bollardière
Chief Executive Officer
Pascal Ghoson
Chief Scientific Officer
Philippe Barbeaux
VP - Bus. Development
Andy De Deene
Browse more venture capital transactions:
Prev: 3/5/2024: Catalog venture capital transaction
Next: 3/5/2024: Taalas venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. All VC database entries on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs